JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5901
Immix Biopharma
IMMX
$840M
| $27.8K | ﹤0.01% |
9,039
+8,361
| +1,233% | +$32.4K |
2023 Q3
2 quarters
|
|
|
KZR
5902
DELISTED
Kezar Life Sciences
KZR
| $27.5K | ﹤0.01% |
3,046
-1,580
| -34% | -$14.4K |
2018 Q3
22 quarters
|
|
5903
System1
SST
$20M
| $27.4K | ﹤0.01% |
1,399
-1,788
| -56% | -$30.5K |
2023 Q2
3 quarters
|
|
5904
Pacer Trendpilot 100 ETF
PTNQ
$1.31B
| $27.4K | ﹤0.01% |
398
+4
| +1% | +$269 |
2023 Q1
4 quarters
|
|
5905
ProShares Bitcoin Strategy ETF
BITO
$1.73B
| $27.3K | ﹤0.01% |
+845
| New | +$21.3K |
2024 Q1
0 quarters
|
|
|
GORV
5906
DELISTED
Lazydays
GORV
| $27.3K | ﹤0.01% |
225
+43
| +24% | +$5.99K |
2023 Q2
3 quarters
|
|
5907
Enlivex Ltd
ENLV
$7.21M
| $27.1K | ﹤0.01% |
477
+461
| +2,881% | +$22.5K |
2022 Q4
5 quarters
|
|
5908
DFA Real Estate Securities Portfolio ETF Class Shares
DFAR
$1.62B
| $27K | ﹤0.01% |
1,208
-2,004
| -62% | -$44.2K |
2022 Q3
6 quarters
|
|
5909
Rallybio
RLYB
$89.8M
| $27K | ﹤0.01% |
1,824
-673
| -27% | -$9.38K |
2021 Q3
10 quarters
|
|
5910
CALL
Microchip Technology
MCHP
$44.2B
| $26.9K | ﹤0.01% |
+300
| New | +$25.9K |
2024 Q1
0 quarters
|
|
5911
Immuneering
IMRX
$261M
| $26.8K | ﹤0.01% |
9,289
-6,785
| -42% | -$38K |
2021 Q3
10 quarters
|
|
|
NIE
5912
Virtus Equity & Convertible Income Fund
NIE
$688M
| $26.5K | ﹤0.01% |
1,185
-10,002
| -89% | -$217K |
2023 Q1
4 quarters
|
|
|
CARM
5913
DELISTED
Carisma Therapeutics
CARM
| $26.5K | ﹤0.01% |
11,681
-5,893
| -34% | -$14.2K |
2021 Q2
11 quarters
|
|
|
LPTV
5914
DELISTED
Loop Media, Inc.
LPTV
| $26.5K | ﹤0.01% |
72,348
+35,866
| +98% | +$21.9K |
2023 Q2
3 quarters
|
|
|
BBSA
5915
DELISTED
JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF
BBSA
| $26.5K | ﹤0.01% |
555
+8
| +1% | +$381 |
2019 Q2
19 quarters
|
|
|
CUTR
5916
DELISTED
Cutera, Inc.
CUTR
| $26.4K | ﹤0.01% |
17,975
+5,739
| +47% | +$14.9K |
2016 Q4
29 quarters
|
|
5917
Bridger Aerospace
BAER
$38.8M
| $26.4K | ﹤0.01% |
+5,263
| New | +$29.2K |
2024 Q1
0 quarters
|
|
5918
Caesarstone
CSTE
$101M
| $26.2K | ﹤0.01% |
6,409
-18,904
| -75% | -$77.4K |
2013 Q2
43 quarters
|
|
5919
BV Financial
BVFL
$182M
| $26.2K | ﹤0.01% |
2,532
+2,473
| +4,192% | +$31.6K |
2023 Q4
1 quarter
|
|
5920
Saba Opportunistically Hedged Closed-End Funds ETF
CEFS
$436M
| $26.1K | ﹤0.01% |
+1,263
| New | +$24.7K |
2024 Q1
0 quarters
|
|
5921
CALL
Affirm
AFRM
$25.2B
| $26.1K | ﹤0.01% |
700
-1,600
| -70% | -$63.9K |
2023 Q4
1 quarter
|
|
5922
Tortoise North American Pipeline ETF
TPYP
$844M
| $26.1K | ﹤0.01% |
932
-481
| -34% | -$12.7K |
2019 Q3
18 quarters
|
|
5923
ECARX Holdings
ECX
$327M
| $25.9K | ﹤0.01% |
13,238
+11,603
| +710% | +$28.3K |
2023 Q2
3 quarters
|
|
5924
Franklin FTSE Brazil ETF
FLBR
$716M
| $25.9K | ﹤0.01% |
+1,322
| New | +$26.3K |
2024 Q1
0 quarters
|
|
5925
Southland Holdings
SLND
$35.9M
| $25.8K | ﹤0.01% |
5,008
+1,031
| +26% | +$5.11K |
2023 Q2
3 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.